Mohammed Talaat RASHID, Waleed ASKAR, Ahmed GAAFAR, Mohamed FAWZY, Mahmoud Abul MAKAREM

Superior Mesenteric artery thrombosis as a possible presenting complication of COVID-19

COVID19 is the designated name given by the WHO for the corona virus disease caused by the virus SARS-COV-2 that was initially identified in the late 2019 and progressed to be a world pandemic.Patients with COVID-19 may have a wide range of coagulation abnormalities (in the direction of an underlying hypercoagulable state), raising questions about appropriate evaluations and interventions to prevent or treat thrombosis. Hypercoagulable state associated with COVID-19 has been repeatedly reported. The prevalence of venous thromboembolism is increasing, especially in the critically ill patient in spite of prophylactic use of anticoagulation. [1-3]. Arterial thrombosis has also been reported but the prevalence is not known. [3]. In this case report, we present a 37 years old man who suffered an acute abdomen due to superior mesenteric artery thrombosis as a possible complication of the COVID-19.

PDF

___

1. Alessandro C, Flora P, Ida M. Where do we stand with antithrombotic prophylaxis in patients with COVID-19? Thrombos Res. 2020;4:23.

2. American College of Cardiology. ‘Feature | Thrombosis and COVID-19: FAQs For Current Practice’. hwww.acc.org%2flatest-in-cardiology%2fart icles%2f2020%2f04%2f17%2f14%2f42%2fthrombosis-and-coronavirusdisease-2019-covid-19-faqs-for-current-practice. accessed date 17 May 2020.

3. Akima S, McLintock C, Hunt BJ. ISTH interim guidance to recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18:2057-8.

4. Björnsson S, Resch T, Acosta S. Symptomatic mesenteric atherosclerotic disease-lessons learned from the diagnostic workup. J Gastrointest Surg. 2013;17:973-80.

5. Boley SJ, Brandt LJ, Sammartano RJ. History of mesenteric ischemia. the evolution of a diagnosis and management. Surg Clin North Am. 1997;77:275–88.

6. FA Klok, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically Ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7.

7. Magro CM, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13.

8. McKinsey JF, Gewertz. BL. Acute mesenteric ischemia. Surg Clin North Am. 1997;77:307–18.

9. Middeldorp S, Coppens M, Thijs F. et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18:1995-2002.

10. Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738-42.

11. Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020l;18:1747-51.

12. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094-9.

13. Beccara L, Pacioni C, Ponton S, et al. Arterial mesenteric thrombosis as a complication fo SARS-CoV-2 infection. Eur J Case Rep Intern Med. 2020;7:001690.